Skip to main content
Log in

Binding cells of125I-iodoamphetamine in rat liver

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

We recently reported that transrectal or intestinal portal scintigraphy with123I-iodoamphetamine (IMP) could be a useful method for the non-invasive and quantitative evaluation of the portosystemic shunt in portal hypertension, but what cells in the liver trap IMP has not been clarified. This study was aimed at elucidating whether IMP was extracted by parenchymal cells, sinusoidal endothelial cells, Kupffer cells or fat storing cells. Each type of liver cell was isolated from rats and cultured. The cells were incubated with125I-IMP and the radioactivity of the lysate was determined. Nonspecific binding was assessed in the presence of an excess of unlabeled IMP, and specific binding was determined by subtracting the nonspecific from total binding. Specific binding observed in parenchymal cells, endothelial cells and Kupffer cells was 70.2 ± 0.4, 4.2 ± 1.4 and 2.3 ±0.8 pmol/well, respectively, but no specific binding was observed in fat storing cells. The binding in parenchymal cells was much higher than that in endothelial cells or Kupffer cells (p < 0.005). In addition, the binding to parenchymal cells reached equilibrium within 20 min and was not saturable over the concentration range tested (0.5–10 μM). These findings indicate that IMP is mostly extracted by parenchymal cells in the liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kuhl DE, Barrio JR, Huang S-C, Selin C, Ackermann RF, Lear JL, et al. Quantifying local cerebral blood flow by Nisopropyl-p-[I-123]iodoamphetamine (IMP) tomography.J Nucl Med 23: 196–203, 1982.

    PubMed  CAS  Google Scholar 

  2. Lee RGL, Hill TC, Holman BL, Uren R, Clouse ME. Comparison of N-isopropyl(I-123)p-iodoamphetamine brain scans using Anger camera scintigraphy and single-photon emission tomography.Radiology 145: 789–793, 1982.

    PubMed  CAS  Google Scholar 

  3. Van Zandwijk N, Zwijnenburg A, Hoefnagel CA, Marcuse HR. N-isopropyl-p[I-123]iodoamphetamine, a new agent for lung imaging studies.Thorax 41: 801–803, 1986.

    Article  PubMed  Google Scholar 

  4. Nakajo M, Uchiyama N, Hiraki Y, Miyata Y, Iriki A, Hirotsu Y, et al. Increased accumulation of iodine-123-IMP in the pulmonary inflammatory lesion surrounding a lung cancer.Ann Nucl Med 2: 49–53, 1988.

    Article  PubMed  CAS  Google Scholar 

  5. Nakajo M, Uchiyama N, Shimada J, Shinohara S, Iriki A, Hirotsu Y, et al. Differentiation of bronchogenic carcinoma from secondary changes, obstructive pneumonitis and/or collapse by I-123 IMP lung imaging.Ann Nucl Med 4: 1–13, 1990.

    Article  PubMed  CAS  Google Scholar 

  6. Yen CK, Pollycove M, Crass R, Lin TH, Baldwin R, Lamb J. Portosystemic shunt fraction quantification with colonic iodine-123 iodoamphetamine.J Nucl Med 27: 1321–1326, 1986.

    PubMed  CAS  Google Scholar 

  7. Kashiwagi T, Azuma M, Ikawa T, Takehara T, Matsuda H, Yoshioka H, et al. Portosystemic shunting in portal hypertension: evaluation with portal scintigraphy with transrectally administered I-123 IMP.Radiology 169: 137–140, 1988.

    PubMed  CAS  Google Scholar 

  8. Rahimian J, Glass EC, Touya JJ, Akber SF, Graham LS, Bennett LR. Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique.J Nucl Med 25: 31–37, 1984.

    PubMed  CAS  Google Scholar 

  9. Hijioka T, Rosenberg RL, Lemasters JJ, Thurman RG. Kupffer cells contain voltage-dependent calcium channels.Mol Pharmacol 41: 435–440, 1992.

    PubMed  CAS  Google Scholar 

  10. Sleyster ECH, Westerhuis FG, Knook DL. The purification of nonparenchymal liver cell classes by centrifugal elutriation.In: Knook DL, Wisse E, eds. Sinusoidal Liver Cells. Amsterdam: Elsevier Biochemical, pp. 289–298, 1982.

    Google Scholar 

  11. Pertoft H, Smedsrod B. Separation and characterization of liver cells.In: Pretlow II TG, Pretlow TP, eds. Cell Separation; Methods and Selected Applications. Vol. 4. New York: Academic Press, pp. 1–24, 1987.

    Google Scholar 

  12. Nagelkerke JF, Barto KP, van Berkel T-JC.In vivo andin vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells.J Biol Chem 258: 12221–12227, 1983.

    PubMed  CAS  Google Scholar 

  13. Doolittle M, Bohman R, Durstenfeld A, Cascarano J, Identification and characterization of liver nonparenchymal cells by flow cytometry.Hepatology 7: 696–703, 1987.

    Article  PubMed  CAS  Google Scholar 

  14. Touya JJ, Rahimian J, Grubbs DE, Corbus HF, Bennett R. A noninvasive procedure forin vivo assay of a ling amine endothelial receptor.J Nucl Med 26: 1302–1307, 1985.

    PubMed  CAS  Google Scholar 

  15. Kosuda S, Kawahara S, Ishibashi A, Tamura K, Kubo A, Hashimoto S. Experimental study of N-isopropyl-p-iodoamphetamine lung uptake.KAKU IGAKU (Jpn J Nucl Med) 27: 149–153, 1990.

    CAS  Google Scholar 

  16. Ito T, Sasaki Y, Hayashi N, Sato N, Kamada T, Kashiwagi T, et al. Determination of intrahepatic distribution of IMP by microautoradiography (abstr).KAKU IGAKU (Jpn J Nucl Med) 26: 1053, 1989.

    Google Scholar 

  17. Tanaka E, Mishima M, Kawakami K, Sakai N, Sugiura N, Taniguchi T, et al. N-isopropyl-p-iodoamphetamine receptors in normal and cancerous tissue of the lung.Eur J Nucl Med 20: 293–296, 1993.

    Article  PubMed  CAS  Google Scholar 

  18. Mori H, Shiba K, Tsuji S, Matsuda H, Hisada K. Binding sites and subcellular distribution of N-isopropyl-p-(I-125)iodoamphetamine in the rat brain.KAKU IGAKU (Jpn J Nucl Med) 23: 1585–1594, 1986.

    CAS  Google Scholar 

  19. Kosuda S, Kawahara S, Ishibashi A, Tamura K, Kubo A, Hashimoto S. Experimental study on liver accumulation of N-isopropyl-p-iodoamphetamine.KAKU IGAKU (Jpn J Nucl Med) 27: 599–605, 1990.

    CAS  Google Scholar 

  20. Howlett DR, Nahorski SR. Quantitative assessment of heterogenous H—spiperone binding to rat neostriatum and frontal cortex.Life Sciences 26: 511–517, 1980.

    Article  PubMed  CAS  Google Scholar 

  21. Mousseau DD, Layrargues GP, Butterworth RF. Region-selective decreases in densities of [3H]tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.J Neurochem 62: 621–625, 1994.

    Article  PubMed  CAS  Google Scholar 

  22. Joulin Y, Moretti JL, Hoellinger H, Defer G. Fate of isopropyl-iodoamphetamine (IMP) in rat liver microsomes.Nucl Med Commun 13: 99–105, 1992.

    PubMed  CAS  Google Scholar 

  23. Meredith MJ. Rat hepatocytes prepared without collagenase: Prolonged retention of differentiated characteristics in culture.Cell Biol & Toxicol 4: 405–425, 1988.

    Article  CAS  Google Scholar 

  24. Fukui H, Kashiwagi T, Kasahara T, Takei Y, Hijioka T, Goto M, et al. Evaluation of effective portal venous flow in chronic liver diseases using echo-Doppler flowmetry combined with per jejunal portal scintigraphy.J Nucl Med 34: 1103–1108, 1993.

    PubMed  CAS  Google Scholar 

  25. Kashiwagi T, Fukui H, Kozuka T, Goto M, Takei Y, Kasahara A, et al. Assessment of portosystemic shunting from superior mesentric vein by duodenal administration of I-123 iodoamphetamine.Eur J Nucl Med 19: 181–185, 1992.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hijioka, T., Kashiwagi, T., Ito, T. et al. Binding cells of125I-iodoamphetamine in rat liver. Ann Nucl Med 11, 27–32 (1997). https://doi.org/10.1007/BF03164754

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164754

Key words

Navigation